NCT03478553Recruiting
The Genetics of Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis, a Disease Initiated by Mucociliary Dysfunction
Source: ClinicalTrials.gov · Last updated 25 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study seeks to screen first degree family members of people with Idiopathic Pulmonary Fibrosis (IPF) for the earliest signs of lung fibrosis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 12 Mar 2018
- Start date
- 18 Jan 2018
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- University of Colorado, Denver
- Diseases
- Idiopathic pulmonary fibrosis
- NCT number
- NCT03478553
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 18 Jan 2018 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- No family member with IPF
Who the study is looking for
- Age at least 18 years old
- Family member diagnosed with IPF
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Colorado Anschutz Medical Campus Coordinator of this site? Confirm its status | Aurora | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.